Susquehanna International Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-68,200
| Closed | -$8K | – | 10463 |
|
|
2018
Q4 | $8K | Buy |
68,200
+17,300
| +34% | +$11.4K | ﹤0.01% | 8765 |
|
|
2018
Q3 | $87K | Sell |
50,900
-238,100
| -82% | -$426K | ﹤0.01% | 8658 |
|
|
2018
Q2 | $503K | Buy |
289,000
+96,000
| +50% | +$166K | ﹤0.01% | 6775 |
|
|
2018
Q1 | $353K | Sell |
193,000
-61,700
| -24% | -$130K | ﹤0.01% | 7350 |
|
|
2017
Q4 | $568K | Buy |
254,700
+101,800
| +67% | +$253K | ﹤0.01% | 6399 |
|
|
2017
Q3 | $443K | Sell |
152,900
-71,000
| -32% | -$242K | ﹤0.01% | 6719 |
|
|
2017
Q2 | $996K | Sell |
223,900
-268,100
| -54% | -$1.11M | ﹤0.01% | 5268 |
|
|
2017
Q1 | $2.29M | Buy |
492,000
+178,000
| +57% | +$1.03M | ﹤0.01% | 3459 |
|
|
2016
Q4 | $1.91M | Buy |
314,000
+107,200
| +52% | +$560K | ﹤0.01% | 4161 |
|
|
2016
Q3 | $1.14M | Buy |
206,800
+114,500
| +124% | +$536K | ﹤0.01% | 4562 |
|
|
2016
Q2 | $351K | Sell |
92,300
-1,900
| -2% | -$6.44K | ﹤0.01% | 6711 |
|
|
2016
Q1 | $260K | Sell |
94,200
-103,300
| -52% | -$374K | ﹤0.01% | 7502 |
|
|
2015
Q4 | $1.12M | Sell |
197,500
-77,100
| -28% | -$470K | ﹤0.01% | 5186 |
|
|
2015
Q3 | $1.46M | Sell |
274,600
-241,200
| -47% | -$1.87M | ﹤0.01% | 4938 |
|
|
2015
Q2 | $4.28M | Buy |
515,800
+474,300
| +1,143% | +$2.3M | ﹤0.01% | 3167 |
|
|
2015
Q1 | $192K | Buy |
+41,500
| New | +$135K | ﹤0.01% | 8665 |
|
|
2014
Q4 | – | Sell |
-109,400
| Closed | -$305K | – | 10337 |
|
|
2014
Q3 | $305K | Sell |
109,400
-67,300
| -38% | -$244K | ﹤0.01% | 8008 |
|
|
2014
Q2 | $719K | Sell |
176,700
-96,800
| -35% | -$411K | ﹤0.01% | 6750 |
|
|
2014
Q1 | $1.45M | Buy |
273,500
+129,208
| +90% | +$724K | ﹤0.01% | 4859 |
|
|
2013
Q4 | $801K | Buy |
144,292
+59,826
| +71% | +$258K | ﹤0.01% | 5889 |
|
|
2013
Q3 | $381K | Buy |
84,466
+71,791
| +566% | +$322K | ﹤0.01% | 6850 |
|
|
2013
Q2 | $54K | Buy |
+12,675
| New | +$63.7K | ﹤0.01% | 7963 |
|
Other funds holding SGYP
Susquehanna International Group's SGYP Position: Q1 2019 in Review
Susquehanna International Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 1,236,697 shares — an estimated $141K sold.
Susquehanna International Group first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $31.9M in Q4 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Susquehanna International Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Susquehanna International Group sold 1,236,697 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $141K.
- Susquehanna International Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Susquehanna International Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $31.9M in Q4 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.